Themis Medicare Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹109.90
Market cap
1,012 Cr
Stock P/E
39.8
P/B
2.54
Dividend yield
0.5%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales97 Cr201 Cr284 Cr382 Cr123 Cr240 Cr94 Cr72 Cr98 Cr78 Cr90 Cr77 Cr
Operating expenses (approx.)74 Cr164 Cr238 Cr326 Cr93 Cr192 Cr84 Cr76 Cr106 Cr78 Cr80 Cr69 Cr
EBITDA22 Cr37 Cr46 Cr56 Cr30 Cr48 Cr10 Cr-4 Cr-9 Cr0.15 Cr10 Cr7 Cr
OPM %23.2%18.5%16.2%14.7%24.5%20.2%10.2%-5.9%-9.1%0.2%11.3%9.7%
Other income0.65 Cr3 Cr4 Cr5 Cr0.96 Cr2 Cr1 Cr2 Cr1 Cr3 Cr1 Cr4 Cr
Interest2 Cr5 Cr7 Cr9 Cr2 Cr5 Cr3 Cr2 Cr2 Cr3 Cr3 Cr3 Cr
Depreciation3 Cr6 Cr9 Cr12 Cr2 Cr5 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr
Profit before tax17 Cr27 Cr29 Cr35 Cr25 Cr39 Cr4 Cr-9 Cr-14 Cr-5 Cr5 Cr2 Cr
Tax %25.6%26.2%26.5%28.6%26.3%26.2%27.0%15.9%-1.1%-3.2%6.0%8.0%
Net profit18 Cr30 Cr37 Cr44 Cr25 Cr39 Cr0.52 Cr-10 Cr-14 Cr-4 Cr10 Cr9 Cr
EPS (₹)₹19.77₹32.07₹4.01₹4.73₹2.68₹4.23₹0.06₹-1.05₹-1.54₹-0.39₹1.10₹0.96

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales184 Cr202 Cr231 Cr395 Cr354 Cr382 Cr406 Cr342 CrSign in for TTM
Operating expenses (approx.)179 Cr162 Cr178 Cr292 Cr287 Cr330 Cr352 Cr333 CrSign in for TTM
EBITDA5 Cr39 Cr53 Cr102 Cr67 Cr52 Cr54 Cr9 CrSign in for TTM
OPM %2.7%19.4%23.0%25.9%19.0%13.5%13.2%2.6%Sign in for TTM
Other income3 Cr3 Cr4 Cr7 Cr12 Cr5 Cr5 Cr9 CrSign in for TTM
Interest12 Cr13 Cr13 Cr9 Cr10 Cr9 Cr10 Cr11 CrSign in for TTM
Depreciation8 Cr8 Cr9 Cr9 Cr10 Cr12 Cr10 Cr10 CrSign in for TTM
Profit before tax-15 Cr18 Cr32 Cr84 Cr59 Cr35 Cr34 Cr-12 CrSign in for TTM
Tax %12.4%11.6%17.7%26.7%26.5%28.6%29.2%-6.5%Sign in for TTM
Net profit-11 Cr25 Cr36 Cr73 Cr57 Cr44 Cr30 Cr1 CrSign in for TTM
EPS (₹)₹-11.72₹26.97₹38.86₹79.22₹61.83₹4.73₹3.24₹0.12Sign in for TTM
Dividend payout %———5.4%8.1%10.6%15.4%402.4%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Equity capital9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr
Reserves114 Cr139 Cr0.0000 Cr244 Cr296 Cr368 Cr360 Cr357 Cr
Borrowings76 Cr88 Cr79 Cr79 Cr92 Cr96 Cr64 Cr78 Cr
Other liabilities80 Cr78 Cr73 Cr62 Cr83 Cr93 Cr121 Cr121 Cr
Total liabilities299 Cr326 Cr338 Cr384 Cr514 Cr566 Cr588 Cr598 Cr
Fixed assets (net)122 Cr115 Cr130 Cr142 Cr161 Cr168 Cr172 Cr166 Cr
CWIP2 Cr8 Cr2 Cr3 Cr3 Cr3 Cr3 Cr2 Cr
Investments11 Cr11 Cr11 Cr11 Cr0.28 Cr0.37 Cr0.32 Cr0.34 Cr
Other assets151 Cr181 Cr187 Cr215 Cr265 Cr293 Cr304 Cr305 Cr
Total assets299 Cr326 Cr338 Cr384 Cr514 Cr566 Cr588 Cr598 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———34 Cr16 Cr14 Cr35 Cr-3 Cr
Cash from investing———-15 Cr-24 Cr-16 Cr-12 Cr-3 Cr
Cash from financing———-18 Cr0.14 Cr-1 Cr-26 Cr4 Cr
Net cash flow———2 Cr-8 Cr-3 Cr-3 Cr-2 Cr
Free cash flow (OCF − Capex)———14 Cr-13 Cr-4 Cr19 Cr-8 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
ROCE %-2.5%20.8%485.0%36.6%13.2%8.3%9.4%-0.3%
ROE %-8.8%16.7%0.0%28.8%16.8%11.5%7.4%0.3%
Debtor days14518612393149170——
Inventory days394385313195261304402515
Days payable259211165102152204——
Cash conversion cycle280361272186259270402515
Debt / equity0.530.560.430.320.270.250.160.20
Current ratio1.031.171.461.971.901.901.951.84
Net debt / EBITDA0.000.000.000.001.181.671.088.29

Compare with peers

Loading peers…